S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
NASDAQ:APOP

Cellect Biotechnology - APOP Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$13.10
▼
$13.37
50-Day Range
$7.54
▼
$13.40
52-Week Range
$6.64
▼
$35.52
Volume
17,400 shs
Average Volume
479,845 shs
Market Capitalization
$12.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

APOP stock logo

About Cellect Biotechnology (NASDAQ:APOP) Stock

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Stock News Headlines

November 24, 2022 | morningstar.com
Why These Biotech Stocks Are Outperforming the Market
November 16, 2022 | realmoney.thestreet.com
Seeing Good Action in Biotechnology Stocks
January 30, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
September 18, 2022 | fool.co.uk
Investing in Biotech: Top UK Biotech Stocks in 2022
November 4, 2021 | finance.yahoo.com
Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer
November 2, 2021 | finance.yahoo.com
Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia
October 15, 2021 | finance.yahoo.com
Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals
October 14, 2021 | finanznachrichten.de
Cellect Biotechnology Ltd.: Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
September 27, 2021 | benzinga.com
Why Cellect Biotechnology Shares Are Rising Today
September 27, 2021 | finance.yahoo.com
Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
September 3, 2021 | markets.businessinsider.com
Pre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…
September 2, 2021 | finance.yahoo.com
Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.
August 24, 2021 | finance.yahoo.com
Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
August 13, 2021 | finance.yahoo.com
The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals
July 27, 2021 | nasdaq.com
Cellect Biotechnology Ltd. American Depositary Shares (APOP)
June 17, 2021 | baystreet.ca
Cellect Registers Merger Agreement
June 17, 2021 | msn.com
Why Are Cellect Biotechnology (APOP) Shares Surging Today?
June 16, 2021 | finance.yahoo.com
Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals
May 17, 2021 | finance.yahoo.com
/R E P E A T -- Halo Collective Inc. Reports Record First Quarter Results/
May 17, 2021 | finance.yahoo.com
Halo Collective Inc. Reports Record First Quarter Results
April 19, 2021 | finance.yahoo.com
Cellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD Study
April 19, 2021 | finance.yahoo.com
Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical Trial
March 29, 2021 | finance.yahoo.com
Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
March 26, 2021 | finanznachrichten.de
Cellect Biotechnology Ltd.: Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger
March 25, 2021 | baystreet.ca
Cellect Jumps on Quoin Hookup
March 25, 2021 | msn.com
Why Is It Moving? Looking Into Why Cellect Biotechnology's Stock is Trading Higher Today
See More Headlines

Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Company Calendar

Last Earnings
11/13/2018
Today
1/29/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APOP
CUSIP
N/A
CIK
1671502
Web
www.cellect.co
Phone
(729) 974-1444
Fax
972-9767-8750
Employees
2,020
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.01
Quick Ratio
3.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
2.76

Miscellaneous

Outstanding Shares
977,000
Free Float
N/A
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.87

Key Executives

  • Shai Yarkoni
    Chief Executive Officer & Director
  • Amos Ofer
    Chief Operating Officer
  • Yaron Ben-Oz
    Chief Financial Officer

Key Competitors

View All Competitors













APOP Stock - Frequently Asked Questions

How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) announced its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02.

When did Cellect Biotechnology's stock split?

Cellect Biotechnology's stock split on the morning of Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were payable to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

What is Cellect Biotechnology's stock symbol?

Cellect Biotechnology trades on the NASDAQ under the ticker symbol "APOP."

What is Cellect Biotechnology's stock price today?

One share of APOP stock can currently be purchased for approximately $13.17.

How much money does Cellect Biotechnology make?

Cellect Biotechnology (NASDAQ:APOP) has a market capitalization of $12.87 million.

How many employees does Cellect Biotechnology have?

The company employs 2,020 workers across the globe.

How can I contact Cellect Biotechnology?

Cellect Biotechnology's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The official website for the company is www.cellect.co. The company can be reached via phone at (729) 974-1444, via email at ir@cellectbio.com, or via fax at 972-9767-8750.

This page (NASDAQ:APOP) was last updated on 1/30/2023 by MarketBeat.com Staff